A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models.

Area of Science:

• Oncology
• Gastroenterology
• Translational Medicine

Background:

• Pseudomyxoma peritonei (PMP) is a rare malignancy with slow growth, posing challenges for preclinical modeling.
• Existing PMP models do not fully capture the disease's unique characteristics.
• There is a critical need for advanced PMP models for research and therapeutic development.

Purpose of the Study:

• To establish a novel culture strategy for generating patient-derived organoid models of pseudomyxoma peritonei.
• To create organoid models that accurately reflect the biological and genetic features of PMP.

Main Methods:

• Utilized a combinatorial culture approach to mimic the PMP microenvironment.
• Incorporated essential growth factors crucial for PMP progression.
• Cultured patient-derived PMP samples under specific conditions.

Main Results:

• Successfully generated 12 distinct PMP organoid models.
• Achieved long-term expansion capacity in the developed organoids.
• Confirmed that organoids replicate the genetic landscape and histological phenotype of the original tumors.

Conclusions:

• The developed organoids serve as faithful preclinical models of PMP.
• These models will facilitate understanding of PMP biology and progression.
• Organoids provide a platform for identifying biomarkers, therapeutic targets, and conducting preclinical testing.